居住地与癌症中心的距离及机器人辅助肺叶切除术后的预后
Residential Distance to the Cancer Center and Outcomes after Robotic-Assisted Pulmonary Lobectomy.
作者信息
Dumitriu Carcoana Allison O, Marek Jenna C, West William J, Fiedler Cole R, Doyle William N, Labib Kristie M, Ladehoff Lauren C, Malavet Jose A, Fishberger Gregory, Moodie Carla C, Garrett Joseph R, Tew Jenna R, Baldonado Jobelle J A R, Fontaine Jacques P, Toloza Eric M
机构信息
Department of Medical Education, University of South Florida Health Morsani College of Medicine, Tampa, FL, USA.
Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, FL, USA.
出版信息
Surg Pract Sci. 2023 Aug 25;15:100210. doi: 10.1016/j.sipas.2023.100210. eCollection 2023 Dec.
BACKGROUND
Outcomes of lung cancer patients traveling greater distances for surgical oncology care are not well-described. We investigated the effects of increased travel burden after robotic-assisted pulmonary lobectomy (RAPL) for lung cancer.
METHODS
Clinical characteristics and surgical outcomes of 711 consecutive patients who underwent RAPL from September 2010 to March 2022 were compared, stratified by primary residential ZIP code <160 km or ≥160 km from the cancer center.
RESULTS
Of 711 study patients, 515 (72.4%) lived within 160 km and 196 (27.6%) lived ≥160 km away. There were no differences in Charlson Comorbidity Index scores or tumor characteristics. Those traveling ≥160 km experienced more unfavorable perioperative outcomes and postoperative complications, and had worse median survival time by 1.68 years, but this survival difference did not reach statistical significance.
CONCLUSIONS
With the growing centralization of cancer care, travel burden may emerge as a predictor of surgical oncology outcomes.
背景
肺癌患者前往更远处接受外科肿瘤治疗的结果尚未得到充分描述。我们研究了肺癌患者在接受机器人辅助肺叶切除术（RAPL）后旅行负担增加的影响。
方法
比较了2010年9月至2022年3月期间连续接受RAPL的711例患者的临床特征和手术结果，根据患者主要居住地邮政编码与癌症中心的距离<160公里或≥160公里进行分层。
结果
在711例研究患者中，515例（72.4%）居住在距离癌症中心160公里以内，196例（27.6%）居住在距离癌症中心≥160公里以外。Charlson合并症指数评分或肿瘤特征方面无差异。那些旅行距离≥160公里的患者围手术期结果和术后并发症更不理想，中位生存时间缩短1.68年，但这种生存差异未达到统计学意义。
结论
随着癌症治疗的日益集中，旅行负担可能成为外科肿瘤治疗结果的一个预测因素。
Zotero 插件